BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27314680)

  • 1. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
    Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
    Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
    Wang H; Chen H; Zhou H; Yu W; Lu Z
    Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
    Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
    Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
    Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
    Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
    Deng X; Wu X; Weng H; Song F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer.
    Yang C; Sun JJ
    Asian Pac J Cancer Prev; 2015; 16(3):965-70. PubMed ID: 25735390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
    Qin B; Cheng K
    Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
    Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
    Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
    Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
    PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
    Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
    Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
    Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
    Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
    Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
    Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CDKN3 in cervical cancer.
    Berumen J; Espinosa AM; Medina I
    Expert Opin Ther Targets; 2014 Oct; 18(10):1149-62. PubMed ID: 25152075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.
    Han H; Yang S; Lin SG; Xu CS; Han ZH
    Mol Med Rep; 2014 Dec; 10(6):3092-8. PubMed ID: 25323004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.